David Pauling SEC EDGAR Filings (CIK 0002063633)

SEC EDGAR filings, ownership reports, and insider transactions for David Pauling.

Business address
C/O Sutro Biopharma, Inc., 111 Oyster Point Boulevard, South San Francisco, CA, 94080
Top holdings (ownership)
STRO
Get insider transactions for this reporting owner
David Pauling has filed 7 SEC EDGAR filings since 08 Apr 2025

Latest Filings

Recent SEC filings for David Pauling including 4, 3/A, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 06 Mar 2026 04 Mar 2026 001-38662
4 Open 4 document View SEC filing for 4 03 Mar 2026 01 Mar 2026 001-38662
4 Open 4 document View SEC filing for 4 29 Dec 2025 23 Dec 2025 001-38662
4 Open 4 document View SEC filing for 4 16 Oct 2025 15 Oct 2025 001-38662
3/A Open 3/A document View SEC filing for 3/A 12 Sep 2025 04 Apr 2025 001-38662
4 Open 4 document View SEC filing for 4 08 Apr 2025 04 Apr 2025 001-38662
3 Open 3 document View SEC filing for 3 08 Apr 2025 04 Apr 2025 001-38662

About this filer

David Pauling files with the SEC under CIK 0002063633. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages